Indiana University School of Medicine is pleased to welcome new faculty member, Weidong Xiao, PhD, a world-renowned authority in gene therapy. Xiao’s expertise includes the development of a molecular tool for the transfer of genes called adeno-associated viral (AAV) vectors.
Nearly 200,000 US children live with Type 1 diabetes.Diabetes daily management requires regular blood sugar checks, monitored diets, and insulin therapy. Therapy costs and the number of persons affected by the disease both are steadily increasing. Disease prevention and cures are urgently needed.
Wade Clapp, MD, has received the Friedrich von Recklinghausen Award in recognition of his significant contributions to neurofibromatosis research and clinical care. Work in his lab at IU School of Medicine is leading to new therapies for people living with this debilitating disease which causes tumors to grow on nerves.
Neurofibromatosis Therapeutic Acceleration Program invests in developing Steven Rhodes, MD, PhD, as a physician-scientist committed to studying NF1 and identifying new therapies to interrupt tumor progression before it leads to a deadly cancer.
With all in-person research activities at IU School of Medicine limited to essential research, many laboratories don’t need as many materials as usual, presenting an opportunity for researchers to assist front-line health care workers by donating PPE items.
Liana Apostolova, MD, MSc, FAAN, and Apoorva Sanjay Bharthur At Indiana University School of Medicine, the 2019 fiscal year set another record for NIH-funded research, with the school’s faculty attracting federal support for research targeting Alzheimer’s disease, pediatric health, global research and more. Here are the projects that were awarded the largest grants: 1. Longitudinal […]